Etoposide

Basic Information

Item Value
DrugBank ID DB00773
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 100

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 well-differentiated fetal adenocarcinoma of the lung KG + DL
2 primary pulmonary lymphoma KG + DL
3 pulmonary blastoma KG + DL
4 Ewing sarcoma KG + DL
5 botryoid-type embryonal rhabdomyosarcoma of the vagina KG + DL
6 rhabdomyosarcoma (disease) KG + DL
7 embryonal extrahepatic bile duct rhabdomyosarcoma KG + DL
8 parameningeal embryonal rhabdomyosarcoma KG + DL
9 extrahepatic bile duct rhabdomyosarcoma KG + DL
10 prostate embryonal rhabdomyosarcoma KG + DL
11 liver sarcoma KG + DL
12 lung mixed small cell and squamous cell carcinoma KG + DL
13 uterine corpus sarcoma KG + DL
14 head and neck cancer KG + DL
15 synovial chondromatosis KG + DL
16 orbit sarcoma KG + DL
17 giant cell tumor of soft tissue KG + DL
18 upper aerodigestive tract neoplasm KG + DL
19 sarcoma, avian KG + DL
20 osteoclastic giant cell tumor of pancreas KG + DL
21 solid pseudopapillary carcinoma of pancreas KG + DL
22 pancreatic carcinoma with mixed differentiation KG + DL
23 pancreatic adenocarcinoma KG + DL
24 skull base chordoma KG + DL
25 mixed ductal-endocrine carcinoma of pancreas KG + DL
26 malignant neoplasm of acoustic nerve KG + DL
27 soft palate cancer KG + DL
28 vestibule of mouth cancer KG + DL
29 2q33.1 microdeletion syndrome KG + DL
30 paranasal sinus cancer KG + DL
31 pancreatic intraductal papillary-mucinous carcinoma KG + DL
32 retromolar area cancer KG + DL
33 uveal cancer KG + DL
34 skeletal muscle neoplasm KG + DL
35 inner ear cancer KG + DL
36 pancreatic signet ring cell adenocarcinoma KG + DL
37 middle ear cancer KG + DL
38 adenosarcoma KG + DL
39 myeloid leukemia KG + DL
40 undifferentiated pancreatic carcinoma KG + DL
41 external ear cancer KG + DL
42 pancreatic intraductal papillary-mucinous neoplasm KG + DL
43 malignant exocrine pancreas neoplasm KG + DL
44 extraskeletal Ewing sarcoma/peripheral primitive neuroectodermal tumor KG + DL
45 ganglioneuroblastoma (disease) KG + DL
46 cornea cancer KG + DL
47 Ewing sarcoma/peripheral primitive neuroectodermal tumor of bone KG + DL
48 pancreatic acinar cell cystadenocarcinoma KG + DL
49 pancreatic serous cystadenocarcinoma KG + DL
50 uterine ligament adenosarcoma KG + DL

(Showing top 50 of 100 predictions)

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). This report is for research purposes only and does not constitute medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.